Wolff Schmiegel
Researcher Next ID · RN-032324
Researcher · Medicine
Universitätsklinikum Knappschaftskrankenhaus Bochum
Bochum, Germany
- Works count
- 1,212
- Citation count
- 26,505
- H-index
- 78
- i10-index
- 249
Research interests
Publications
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
Genetics in Medicine · 2019 · https://doi.org/10.1038/s41436-019-0596-9
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(18)32557-1
No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies
Gastroenterology · 2018 · https://doi.org/10.1053/j.gastro.2018.07.030
Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group
Annals of Oncology · 2016 · https://doi.org/10.1093/annonc/mdw261
Risks of Less Common Cancers in Proven Mutation Carriers With Lynch Syndrome
Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2012.43.2278
Efficacy of Annual Colonoscopic Surveillance in Individuals With Hereditary Nonpolyposis Colorectal Cancer
Clinical Gastroenterology and Hepatology · 2009 · https://doi.org/10.1016/j.cgh.2009.10.003
Genotype-Phenotype Comparison of German MLH1 and MSH2 Mutation Carriers Clinically Affected With Lynch Syndrome: A Report by the German HNPCC Consortium
Journal of Clinical Oncology · 2006 · https://doi.org/10.1200/jco.2005.03.7333
Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study
Journal of Clinical Oncology · 2001 · 10.1200/jco.2001.19.21.4097
Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis
Proceedings of the National Academy of Sciences · 2000 · https://doi.org/10.1073/pnas.97.17.9624
Current projects
No projects listed.